Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
rituxan save search
FDA APPROVES RIABNI™ (RITUXIMAB-ARRX), A BIOSIMILAR TO RITUXAN® (RITUXIMAB), FOR ADULTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS
Published: 2022-06-06 (Crawled : 15:20) - biospace.com/
BGNE | $138.615 5.86% 110K
|
Health Technology
|
| O: 7.48%
H: 0.45%
C: -4.8%
AMGN | News | $273.38 0.54% 790K
|
Health Technology
|
| O: -0.32%
H: 0.2%
C: -1.16%
rituxan fda biosimilar
FirstEnergy Donates 500 Trees to Rittman Nature Preserve for Second Year
Published: 2022-05-06 (Crawled : 20:00) - prnewswire.com
FE | $38.36 0.39% 680K
|
Utilities
| Email alert
Add to watchlist
500
FirstEnergy Donates 520 Trees to Rittman Nature Preserve
Published: 2021-10-27 (Crawled : 20:00) - prnewswire.com
FE | $38.36 0.39% 680K
|
Utilities
|
| O: 0.08%
H: 0.85%
C: 0.74%
energy
Global Top Selling Biologics Markets 2021-2030: Humira, Keytruda, Opdivo, Avastin, Rituxan, Stelara, Herceptin, Enbrel
Published: 2021-08-03 (Crawled : 21:00) - prnewswire.com
JNJ | News | $150.09 0.65% 3.9M
|
Health Technology
|
| O: -0.11%
H: 0.22%
C: -0.48%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -1.98%
H: 0.73%
C: -1.19%
keytruda
ImmunityBio Announces 78 Percent Complete Response Following Chemotherapy-Free Combination of IL-15 Superagonist Anktiva with Rituxan in Relapsed Non-Hodgkin Lymphoma Patients
Published: 2021-05-04 (Crawled : 13:15) - nantkwest.com
IBRX | $5.485 11.03% 24M
|
Manufacturing
|
| O: -1.39%
H: 1.18%
C: -7.06%
therapy
FDA Approves Amgen's RIABNI™ (rituximab-arrx), A Biosimilar To Rituxan® (rituximab)
Published: 2020-12-17 (Crawled : 22:01) - biospace.com/
AMGN | News | $273.38 0.54% 790K
|
Health Technology
|
| O: 0.3%
H: 0.99%
C: 0.93%
fda approval fda approval biosimilar
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
PALI | $6.29 27.59% 22M
|
Manufacturing
MCRB | $0.7902 26.51% 6.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.